Research
Research
May 18, 2026 • 3 Min
Accessing Daraxonrasib: A Quick Primer
Daraxonrasib, the first KRAS drug for pancreatic cancer, is now available through an expanded access program, but your physician must apply for you.
An affiliate of the Lustgarten Foundation, the largest private funder of pancreatic cancer research.
Research
March 16, 2026 • 5 Min
Certain Oral Microbes May Raise Pancreatic Cancer Risk
Dr. Jiyoung Ahn is leading research into how the oral microbiome is related to the risk of developing pancreatic cancer.
Research
March 4, 2026 • 4 Min
FDA Approves Tumor Treating Fields For Locally Advanced Disease
Dr. Vincent Picozzi explains how the recently approved tumor treating fields device is changing the game for pancreatic cancer patients.
Survivor Stories
Survivor Stories
November 2, 2022 • 3 Min
Urinary Tract Scans Lead to My Diagnosis
Ellen Robbins has the BRCA2 mutation, and that allowed her to participate in a clinical trial for her pancreatic cancer.
Survivor Stories
June 27, 2022 • 4 Min
Taking a Chance on a Clinical Trial
Reesa Levy traveled to find the right pancreatic cancer doctor for her, and then joined a clinical trial for a vaccine.
Survivor Stories
June 1, 2022 • 5 Min
The Benefit of Multiple Clinical Trials
Dr. Ira Sharp knew that his best bet for surviving pancreatic cancer was to look for clinical trials as part of his treatment.
